Daxin Wang

My former research output:

1. Zhong L, Xu Y1, Zhuo R, Wang T, Wang K, Huang R, Wang D, Gao Y, Zhu Y, Sheng X, Chen K, Wang N, Zhu L, Can D, Marten Y, Shinohara M, Liu CC, Du D, Sun H, Wen L, Xu H, Bu G, Chen XF. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model. Nat Commun. 2019 Mar 25;10(1):1365.

PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30911003 

2. Zhong L*, Wang Z*, Wang D*, Wang Z*, Martens YA*, Wu L, Xu Y, Wang K, Li J, Huang R, Can D, Xu H, Bu G and Chen XF. Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2(TREM2). Mol Neurodegener. 2018, Mar 27;13(1):15. (* equal contribution)

PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29587871 

3. Zhong L, Chen XF, Wang T, Wang Z, Liao C, Wang Z, Huang R, Wang D, Li X, Wu L, Jia L, Zheng H, Painter M, Atagi Y, Liu CC, Zhang YW, Fryer JD, Xu H, Bu G. Soluble TREM2 induces inflammatory responses and enhances microglial survival. J Exp Med. 2017 Mar 6; 214 (3):    597-607.

PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28209725 

4. Yang L, Liu CC, Zheng H, Kanekiyo T, Atagi Y, Jia L, Wang D, N'songo A, Can D, Xu H, Chen XF, Bu G. LRP1 suppresses microglial activation by modulating JNK and NF-κB signaling pathways. J Neuroinflammation. 2016 Dec 8; 13 (1): 304.

PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27931217